Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Jonathan Kulbersh of Carolina Facial Plastics Offers Juvéderm Vycross, the Innovative Technology behind the Facial Fillers Volbella, Vollure, and Voluma
  • USA - English


News provided by

Goldman Marketing Group

Jul 06, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Jonathan Kulbersh - Carolina Facial Plastics
Dr. Jonathan Kulbersh - Carolina Facial Plastics
Youtube
Youtube

“These treatments give patients the safe and effective results they expect with the unexpected but very welcome benefit of longer-lasting results," says Dr. Kulbersh

Post this

Charlotte, NC (PRWEB) July 06, 2017 -- Advancements in medical technology are so rapid that it’s often hard to keep up, and nowhere is this more evident than in cosmetic and medical dermatology and surgery. At Charlotte’s leading boutique aesthetics practice, Carolina Facial Plastics, facial plastic surgeon and founder Dr. Jonathan Kulbersh and staff are at the forefront of the research and implementation of emerging medical technologies. One innovation of particular interest is Juvéderm Vycross, an exciting technology featured in Juvéderm’s line of products, including Voluma, Vollure, and Volbella.

“Carolina Facial Plastics is pleased to offer Vycross in our Volbella, Vollure and Voluma injections,” explains Dr. Kulbersh. “Vycross technology adds an unprecedented dimension to facial fillers that will have a tremendous impact on the industry. With the number of hyaluronic acid fillers on the market, this could be a game-changer that separates Volbella, Vollure, and Voluma from others.”

Hyaluronic acid (HA) is crucial to the body’s moisture levels and in keeping skin soft and supple, so it makes sense that a plethora of HA facial fillers are available. To distinguish itself from rivals, Juvéderm has developed a proprietary technology to deliver safe, effective results that last longer than other HA fillers. In fact, these “next-gen” treatments also result in improved skin tone and lift as well as fewer side effects.

“Vycross technology combines hyaluronic acid molecules of differing weights, which allows the filler gel to have properties that are both supportive and flexible,” Dr. Kulbersh says. “Many injectables are either supportive, which is good for adding lift or volume to areas of lax skin or flexible, which is good for allowing patients to make expressions that look natural; however, not many are both. This gives Volbella and Voluma an advantage, as each treatment is firm enough to improve volume loss in skin yet malleable enough to easily make expressions that look natural, not stiff or frozen.”

These fillers provide correction of moderate to severe wrinkles and facial folds as well as improve smoothness and firmness. Voluma is usually more effective for addressing problem areas in the cheek or mid-face, such as those around the nose and mouth, while Volbella is designed for correcting thinning lips or erasing fine lip lines and wrinkles. For more about these and the rest of the Juvéderm line, as well as information about Dr. Kulbersh’s unique, innovative needle-less injections, visit https://CarolinaFacialPlasticSurgery.com/Facial-Procedures/.

“We’re excited to provide these new fillers as solutions for our patients’ most pressing skin concerns,” Dr. Kulbersh says. “These treatments give patients the safe and effective results they expect with the unexpected but very welcome benefit of longer-lasting results; side effects such as swelling or bruising are also minimized due to the Vycross technology. Because each treatment addresses a specific cosmetic need, our patients now have more choices that allow them to customize their treatments to reach their individual aesthetic goals, and Carolina Facial Plastics is proud to offer this to our patients.”

Double board-certified as a facial plastic surgeon and fellowship-trained in facial plastic and reconstructive surgery, Dr. Jonathan Kulbersh is the founder and director of Carolina Facial Plastics in Charlotte, North Carolina. Dr. Kulbersh received training in facial plastic surgery in Beverly Hills with renowned surgeons, Babak Azizzadeh, MD, FACS, Paul Nassif, MD, FACS, (well known for his show Botched) and Guy Massry, MD. Additionally, Dr. Kulbersh has experience in facial rejuvenation procedures, including facelifts, rhinoplasties, eyelifts, and injectables (Botox and dermal fillers). As an expert in the function of facial nerves, Dr. Kulbersh has a special interest in patients with facial paralysis and Bell’s palsy. Dr. Kulbersh has published numerous articles, as well as chapters of medical textbooks, including Master Techniques in Blepharoplasty and Periorbital Rejuvenation. https://CarolinaFacialPlasticSurgery.com/

Carolina Facial Plastics
6849 Fairview Road #200
Charlotte, NC 28210
(704) 842-3644
info(at)CarolinaFacialPlastics(dot)com

Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.